Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
The shots could begin in early November — with the first children in line fully protected by Christmas — if regulators give the go-ahead.
The Food and Drug Administration announcement marks a big step toward expanding the U.S. booster campaign, which began with extra doses of the Pfizer vaccine last month.
Tuesday's announcement is a long-awaited move intended to make the devices more accessible to millions of Americans with hearing problems.
J&J has asked the Food and Drug Administration for flexibility with its booster, arguing the extra dose adds important protection as early as two months after initial vaccination -- but that it might work better if people wait until six…
The FDA’s Vaccines and Related Biological Products Advisory Committee is expected to hold a meeting on Friday to discuss the emergency authorization of booster doses of the Johnson & Johnson COVID-19 vaccine for people 18 and older.
U.S. health advisors said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19.
For the first time, U.S. health officials have authorized an electronic cigarette, saying the R.J. Reynolds vaping device can benefit adult smokers.
After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters. Then next week, a panel convened by the CDC will offer more specifics on who should get them.
If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat COVID-19.
Support Provided By: